'Future medicines may be designed much like software' — How scientists programmed human cells to compute like tiny processors and target cancer using RNA trans-splicing
THE SO WHAT
Programmable human cells that compute via RNA trans-splicing move therapeutics closer to software-like logic—disease detection and response encoded directly in biology. Biotech operators should be thinking in terms of compilers, verification, and versioning for cell programs, not just molecules.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechFake FBI social media scams are on the rise — here's what to look out for
Attackers are now inserting themselves into the moment of incident reporting, not just the initial fraud. If you run consumer-facing products, assume your users will be socially engineered around your brand and government agencies—tighten verification flows and comms playbooks accordingly.
Deep & Emerging TechSingapore Defence Agencies Partner With IBM to Explore Quantum Computing Applications
Singapore’s defense sector is treating quantum as an operational tool for mission planning and logistics, not just a science project. If you’re in defense or critical infrastructure, this is a cue to map where combinatorial planning and optimization could justify early quantum pilots, even if timelines are uncertain.
.jpg)
Deep & Emerging TechNvidia Wants to Own Every Chip Inside AI Data Centers
By bundling CPUs and GPUs into the Vera Rubin platform, Nvidia is moving from accelerator vendor to full data center compute fabric. If you’re a large buyer, this increases the convenience of a single-stack deployment but raises concentration and lock-in risk—negotiate harder on pricing, interoperability, and exit ramps.
Deep & Emerging TechNvidia Touts Progress Getting New Rubin Design to Customers
Rubin moving into customer hands means Nvidia’s next-gen architecture is transitioning from roadmap to deployment, reinforcing its lead in high-end AI compute. If you’re planning large training runs in 2026–2027, lock in your Rubin access and power footprint now or risk queuing behind better-prepared buyers.